Literature DB >> 26962737

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Thomas Robert1, Alexandra Cambier1, Alexandre Hertig2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26962737     DOI： 10.1056/NEJMc1600141

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

2.  Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.

Authors:  S N Cox; F Pesce; J S El-Sayed Moustafa; F Sallustio; G Serino; C Kkoufou; A Giampetruzzi; N Ancona; M Falchi; F P Schena
Journal:  J Intern Med       Date:  2016-10-11       Impact factor: 8.989

3.  Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.

Authors:  Alexandra Cambier; Marion Rabant; Michel Peuchmaur; Alexandre Hertig; Georges Deschenes; Cecile Couchoud; Anne Kolko; Remi Salomon; Julien Hogan; Thomas Robert
Journal:  Kidney Int Rep       Date:  2018-03-29

4.  Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics.

Authors:  Yawen Bai; Yajing Li; Yali Xi; Chunjie Ma
Journal:  BMC Nephrol       Date:  2022-04-13       Impact factor: 2.388

5.  Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy.

Authors:  Sharon Natasha Cox; Samantha Chiurlia; Chiara Divella; Michele Rossini; Grazia Serino; Mario Bonomini; Vittorio Sirolli; Francesca B Aiello; Gianluigi Zaza; Isabella Squarzoni; Concetta Gangemi; Maria Stangou; Aikaterini Papagianni; Mark Haas; Francesco Paolo Schena
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.